January Recap: What Happened To The ASX 200?
Max Wagner
January 31, 2019
After 2018 saw the S&P/ASX 200 (INDEXASX:XJO) drop by 6.9%,
ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
After 2018 saw the S&P/ASX 200 (INDEXASX:XJO) drop by 6.9%,
The ResMed Inc (ASX:RMD) share price is down another 9.2%
The ResMed Inc (ASX:RMD) share price is down nearly 11%
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX: XAO),
This week, ResMed Inc. (ASX:RMD) announced it will be acquiring
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
ResMed Inc (ASX:RMD) has reported its result for the first
Here are the stories from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
